COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,221 Articles (22,733 medRxiv, 8,488 bioRxiv)

Most recent first Previous |  Page 14: Articles 131-140  | Next

Primary Findings of Nationwide Home-based Test to Treat Program for COVID-19 and Influenza
Soni, A., Home Test to Treat Group
10.1101/2025.11.13.25339276 — Posted: 2025-11-17
Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters and Severity Groups
Peng, B., Zhang, Y., Dalhuisen, T., Rogers, A., Estevez, J., Davies, H. E., Jones, S. J., Capric, V., Haddad, N. S., Miners, K. L., Ladell, K., Martin, J. N., Kelly, J. D., Deeks, S. G., Peluso, M. J., Putrino, D., Price, D. A., Dupont, C. L., Freire, M., VanElzakker, M. B., Proal, A., Scheuermann, R. H., Lee, F. E.-H., Tan, G. S., Qian, Y.
10.1101/2025.11.16.25340350 — Posted: 2025-11-17
Dynamics of interactions between three major respiratory pathogens in reconstituted human epithelium
Gibeaud, A., Terra, C., Portier, E., Lukas, P., Le Gouellec, A., Guedj, J., Graw, F., Pizzorno, A., Terrier, O.
10.1101/2025.11.17.688795 — Posted: 2025-11-17
Evolutionary rewiring of host metabolism and interferon signalling by SARS-CoV-2 variants
Giotis, E. S., Somji, R.-A., Brown, J. C., Rowles-Khalid, S., Abdullahi, T. B., Luo, D., Barthel, N., Mulleder, M., Ralser, M. S., Barclay, W. S. S., Rallis, C.
10.1101/2025.11.15.688605 — Posted: 2025-11-17
Distinct Mechanisms for Inhibition of SARS-CoV-2 Main Protease: Dimerization Promoted by Peptidomimetic Inhibitors and Disrupted by Ebselen
Liu, C., Jia, Q., Zhao, C., Zhongping, Y.
10.1101/2025.11.16.688752 — Posted: 2025-11-17
pH-induced structural changes in SARS-CoV-2 spike variants
Oliveira, A. S. F., Tulli, L., Kearns, K. L., Casalino, L., Rosenfeld, M. A., Berger, I., Schaffitzel, C., Davidson, A. D., Haddrell, A. E., Reid, J. P., Amaro, R. E., Mulholland, A. J.
10.1101/2025.11.17.688702 — Posted: 2025-11-17
What the COVID-19 pandemic teaches us about modelling epidemics: Percolation versus SEIR
Mathiot, J.-F., Gerbaud, L., Breton, V.
10.1101/2025.11.13.25340147 — Posted: 2025-11-15
Third dose COVID-19 vaccination elicits immune memory in patients with inborn errors of immunity even in absence of neutralizing antibodies
Edwards, E. S. J., Gugasyan, R., Varese, N., Sun, S., Canning, J. E., Blight, E. G., Aui, P. M., Boo, I., Turville, S., Aggarwal, A., Ojaimi, S., Bosco, J. J., Stojanovic, S., Hogarth, P. M., Drummer, H. E., Bornheimer, S., O'Hehir, R. E., van Zelm, M. C.
10.1101/2025.11.09.25339598 — Posted: 2025-11-13
LONG COVID RECOVERY AND EXERCISE ADHERENCE: 32-MONTH STUDY
Rolo-Duarte, A., Prada, D., Carvalho, A. S. M., Borges, A., Bettencourt, P. J. G.
10.1101/2025.11.11.25340028 — Posted: 2025-11-13
Mutation and ACE2-induced Allosteric Network Rewiring in Delta and Omicron SARS-CoV-2 Spike Proteins
Dutta, M., Voth, G. A.
10.1101/2025.11.12.688084 — Posted: 2025-11-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).